Company intelligence / Profile preview

Relife Pharmaceuticals

Mumbai, Maharashtra, India

Ownership: Private
Development stage: Commercial

Overview

Relife Pharmaceuticals manufactures and markets standardized pharmaceutical products for both human and animal health care across multiple therapeutic areas. The company has a significant global presence with validated and consistent offerings in major markets worldwide. No specific clinical trial results are disclosed; the focus appears to be on commercialized generic or branded formulations rather than novel drug development.

Therapeutic areas: Men's HealthOtherDermatologyRheumatologyGastroenterologyInfectious Diseases
Modalities: Small moleculeProtein
Industry: Biotech

Beyond the preview

Go deeper on Relife Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relife Pharmaceuticals.

Explore the full profile